ONUREG (azacitidine) is an oral prescription medicine used to treat adults with acute myeloid leukemia (AML) who are in first complete remission (CR) (with or without recovery of your blood cell counts) after intensive induction chemotherapy and are not able to complete intensive curative therapy.
It is not known if ONUREG is safe and effective in children under 18 years of age.
System Error
An error occurred and the resource you requested could not be loaded. Please return to the home page or view the site map.
